TREATMENT OF SUPERIOR VENA-CAVA THROMBOSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR

被引：23
|
作者：
GREENBERG, S
KOSINSKI, R
DANIELS, J
机构：
[1] MONMOUTH MED CTR,DIV CARDIOL,LONG BRANCH,NJ 07740
[2] MONMOUTH MED CTR,DIV HEMATOL MED ONCOL,LONG BRANCH,NJ 07740
来源：
CHEST | 1991年 / 99卷 / 05期
关键词：
D O I：
10.1378/chest.99.5.1298
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Thrombotic occlusion of the superior vena cava is an uncommon but serious complication of chronic indwelling venous catheters. Several reports have shown thrombolytic therapy with intravenous streptokinase or urokinase to be effective in the treatment of this condition. We report a case of superior vena cava thrombosis in a 53-year-old woman receiving chemotherapy for breast carcinoma through a subcutaneously implanted venous access catheter who was successfully treated with peripheral infusion of recombinant tissue type plasminogen activator (rtPA).
引用
收藏
页码：1298 / 1301
页数：4
相关论文
共 50 条
  • [41] ORIGINS OF THE SPECIFICITY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    DING, L
    COOMBS, G
    STRANDBERG, L
    NAVRE, M
    COREY, D
    MADISON, E
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1134 - 1134
  • [42] CLEARANCE RECEPTORS FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    CAMANI, C
    KRUITHOF, EKO
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1994, 60 (02) : 97 - 109
  • [43] THROMBOLYTIC PROPERTIES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 95 - 95
  • [44] TURNOVER OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN MAN
    NILSSON, T
    WALLEN, P
    MELLBRING, G
    HAEMOSTASIS, 1984, 14 (01) : 90 - 90
  • [45] ORIGINS OF THE SPECIFICITY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    COOMBS, G
    DING, L
    STRANDBERG, L
    NAVRE, M
    MADISON, E
    COREY, D
    FASEB JOURNAL, 1995, 9 (06): : A1267 - A1267
  • [46] ORIGINS OF THE SPECIFICITY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    DING, L
    COOMBS, GS
    STRANDBERG, L
    NAVRE, M
    COREY, DR
    MADISON, EL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) : 7627 - 7631
  • [47] TISSUE-TYPE PLASMINOGEN-ACTIVATOR - INTRACORONARY APPLICATIONS
    TIEFENBRUNN, AJ
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1990, 19 (02): : 108 - 115
  • [48] MECHANISMS OF ACTIVATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    FISCHER, B
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-1 (05): : 625 - 632
  • [49] THROMBOLYTIC TREATMENT WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A PATIENT WITH MASSIVE PULMONARY-EMBOLISM
    BOUNAMEAUX, H
    VERMYLEN, J
    COLLEN, D
    ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) : 64 - 65
  • [50] PREVENTION OF CORONARY-THROMBOSIS WITH SUBTHROMBOLYTIC DOSES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    FOX, KAA
    ROBISON, AK
    KNABB, RM
    ROSAMOND, TL
    SOBEL, BE
    BERGMANN, SR
    CIRCULATION, 1985, 72 (06) : 1346 - 1354
12345